Bonraybio Co., Ltd. (TPE:6955)
Taiwan · Delayed Price · Currency is TWD 145.50
-4.50 (-3.00%)
At close: May 29, 2026
Bonraybio Market Cap
Bonraybio has a market cap or net worth of 3.61 billion as of May 29, 2026. Its market cap has increased by 14.22% in one year.
Market Cap
3.61B
Enterprise Value
3.05B
Revenue
319.67M
Ranking
n/a
PE Ratio
35.40
Stock Price
145.50
Market Cap Chart
Since July 25, 2023, Bonraybio's market cap has increased from 1.48B to 3.61B, an increase of 144.44%. That is a compound annual growth rate of 36.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 3.61B | -1.69% |
| Dec 31, 2025 | 3.67B | 24.12% |
| Dec 31, 2024 | 2.96B | 101.25% |
| Dec 29, 2023 | 1.47B | -0.46% |
| Jul 25, 2023 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| United Orthopedic | 8.68B |
| Delta Asia International | 6.05B |
| Hi-Clearance | 5.99B |
| WeLeader Biomedical | 3.05B |
| Applied BioCode | 2.54B |
| A Plus Biotechnology | 2.46B |
| Wellell | 2.40B |
| Medimaging Integrated Solution | 2.38B |